Browse > Article
http://dx.doi.org/10.4062/biomolther.2021.037

Change in Cationic Amino Acid Transport System and Effect of Lysine Pretreatment on Inflammatory State in Amyotrophic Lateral Sclerosis Cell Model  

Latif, Sana (College of Pharmacy and Drug Information Research Institute, Sookmyung Women's University)
Kang, Young-Sook (College of Pharmacy and Drug Information Research Institute, Sookmyung Women's University)
Publication Information
Biomolecules & Therapeutics / v.29, no.5, 2021 , pp. 498-505 More about this Journal
Abstract
Amyotrophic lateral sclerosis (ALS) is a lethal neurological disorder characterized by the deterioration of motor neurons. The aim of this study was to investigate alteration of cationic amino acid transporter (CAT-1) activity in the transport of lysine and the pretreatment effect of lysine on pro-inflammatory states in an amyotrophic lateral sclerosis cell line. The mRNA expression of cationic amino acid transporter 1 was lower in NSC-34/hSOD1G93A (MT) than the control cell line (WT), lysine transport is mediated by CAT-1 in NSC-34 cell lines. The uptake of [3H]L-lysine was Na+-independent, voltage-sensitive, and strongly inhibited by inhibitors and substrates of cationic amino acid transporter 1 (system y+). The transport process involved two saturable processes in both cell lines. In the MT cell line, at a high-affinity site, the affinity was 9.4-fold higher and capacity 24-fold lower than that in the WT; at a low-affinity site, the capacity was 2.3-fold lower than that in the WT cell line. Donepezil and verapamil competitively inhibited [3H]L-lysine uptake in the NSC-34 cell lines. Pretreatment with pro-inflammatory cytokines decreased the uptake of [3H]L-lysine and mRNA expression levels in both cell lines; however, the addition of L-lysine restored the transport activity in the MT cell lines. L-Lysine exhibited neuroprotective effects against pro-inflammatory states in the ALS disease model cell lines. In conclusion, studying the alteration in the expression of transporters and characteristics of lysine transport in ALS can lead to the development of new therapies for neurodegenerative diseases.
Keywords
Amyotrophic lateral sclerosis; NSC-34 cell lines; L-Lysine; Motor neuron disease; Cationic amino acid transporter 1;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kim, C. S., Cho, S. H., Chun, H. S., Lee, S. Y., Endou, H., Kanai, Y. and Kim, D. K. (2008) BCH, an inhibitor of system L amino acid transporters, induces apoptosis in cancer cells. Biol. Pharm. Bull. 31, 1096-1100.   DOI
2 Lee, J., Hyeon, S. J., Im, H., Ryu, H., Kim, Y. and Ryu, H. (2016) Astrocytes and microglia as non-cell autonomous players in the pathogenesis of ALS. Exp. Neurobiol. 25, 233-240.   DOI
3 Lee, N. Y., Kim, Y., Ryu, H. and Kang, Y. S. (2017) The alteration of serine transporter activity in a cell line model of amyotrophic lateral sclerosis (ALS). Biochem. Biophys. Res. Commun. 483, 135-141.   DOI
4 Mitsuoka, K., Shirasaka, Y., Fukush, I. A., Sato, M., Nakamura, T., Nakanishi, T. and Tamai, I. (2009) Transport characteristics of L-citrul-line in renal apical membrane of proximal tubular cells. Biopharm. Drug Dispos. 30, 126-137.   DOI
5 Patten, B. M., Harati, Y., Acosta, L., Jung, S. S. and Felmus, T. M. (1978) Free amino acid levels in amyotrophic lateral sclerosis. Ann. Neurol. 3, 305-309.   DOI
6 Rasouli, S., Abdolvahabi, A., Croom, C. M., Plewman, D. L., Shi, Y., Ayers, J. I. and Shaw, B. F. (2017) Lysine acylation in superoxide dismutase-1 electrostatically inhibits formation of fibrils with prion-like seeding. J. Biol. Chem. 292, 19366-19380.   DOI
7 Rojas, F., Gonzalez, D., Cortes, N., Ampuero, E., Hernandez, D. E., Fritz, E., Abarzua, S., Martinez, A., Elorza, A. A., Alvarez, A., Court, F. and van Zundert, B. (2015) Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling. Front. Cell. Neurosci. 9, 203.   DOI
8 Deves, R., Angelo, S. and Chavez, P. (1993) N-ethylmaleimide discriminates between two lysine transport systems in human erythrocytes. J. Physiol. 468, 753-766.   DOI
9 O'Kane, L. R., Vina, J. R., Simpson, I., Zaragoza, R., Mokashi, A. and Hawkins, R. A. (2006) Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+. Am. J. Physiol. Endocrinol. Metab. 291, E412-E419.   DOI
10 Closs, E. I., Biossel, J. P., Habermerier, A. and Rotmann, A. (2006) Structure and function of cationic amino acid transporters (CATs). J. Membr. Biol. 213, 67-77.   DOI
11 Deves, R. and Boyd, C. A. (1998) Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol. Rev. 78, 487-545.   DOI
12 Furesz, T. C., Moe, A. J. and Smith, C. H. (1991) Two cationic amino acid transport systems in human placental basal plasma membranes. Am. J. Physiol. 261, C246-C252.   DOI
13 Gyawali, A., Gautam, S., Hyeon, S. J., Ryu, H. and Kang, Y. S. (2021) L-citrulline level and transporter activity are altered in experimental models of amyotrophic lateral sclerosis. Mol. Neurobiol. 58, 647-657.   DOI
14 Gyawali, A. and Kang, Y. S. (2019) Blood-to-retina transport of imperatorin involves the carrier-mediated transporter system at the inner blood-retinal barrier. J. Pharm. Sci. 108, 1619-1626.   DOI
15 Van Winkle, L. J., Campione, A. L. and Farrington, B. H. (1990) Development of system B0,+ and a broad-scope Na(+)-dependent transporter of zwitterionic amino acids in preimplantation mouse conceptuses. Biochim. Biophys. Acta 1025, 225-233.   DOI
16 Gyawali, A. and Kang, Y. S. (2021a) Pretreatment effect of inflammatory stimuli and characteristics of tryptophan transport on brain capillary endothelial (TR-BBB) and motor neuron like (NSC-34) cell lines. Biomedicines 9, 9.   DOI
17 Ilzecka, J., Stelmasiak, Z., Solski, J., Wawrzycki, S. and Szpetnar, M. (2003) Plasma amino acids concentration in amyotrophic lateral sclerosis patients. Amino Acids 25, 69-73.   DOI
18 Closs, E. I., Simon, A., Vekony, N. and Rotmann, A. (2004) Plasma membrane transporters for arginine. J. Nutr. 134, 2752S-2759S.
19 Rowland, L. P. and Shneider, N. A. (2001) Amyotrophic lateral sclerosis. N. Engl. J. Med. 344, 1688-1700.   DOI
20 Tomi, M., Kitade, N., Hirose, S., Yokota, N., Akanuma, S., Tachikawa, M. and Hosoya, K. (2009) Cationic amino acid transporter 1-mediated L-arginine transport at the inner blood-retinal barrier. J. Neurochem. 111, 716-725.   DOI
21 Wee, C. Y., Yap, P. T. and Shen, D.; Alzheimer's Disease Neuroimaging Initiative (2013) Prediction of alzheimer's disease and mild cognitive impairment using cortical morphological patterns. Hum. Brain Mapp. 34, 3411-3425.   DOI
22 Zhan, X., Stamova, B., Jin, L. W., DeCarli, C., Phinney, B. and Sharp, F. R. (2016) Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology 87, 2324-2332.   DOI
23 Ayers, J. I., Fromholt, S. E., O'Neal, V. M., Diamond, J. H. and Borchelt, D. R. (2016) Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Acta Neuropathol. 131, 103-114.   DOI
24 Zhang, X., Chen, S., Lu, K., Wang, F., Deng, J., Xu, Z., Wang, X., Zhou, Q., Le, W. and Zhao, Y. (2019) Verapamil ameliorates motor neuron degeneration and improves lifespan in the SOD1G93A mouse model of ALS by enhancing autophagic flux. Aging Dis. 10, 1159-1173.   DOI
25 Lee, N. Y. and Kang, Y. S. (2016) In vivo and in vitro evidence for brain uptake of 4-phenylbutyrate by the monocarboxylate transporter 1 (MCT1). Pharm. Res. 33, 1711-1722.   DOI
26 Ukmar-Godec, T., Hutten, S., Grieshop, M. P., Rezaei-Ghaleh, N., Cima-Omori, M. S., Biernat, J., Mandelkow, E., Soding, J., Dormann, D. and Zweckstetter, M. (2019) Lysine/RNA-interactions drive and regulate biomolecular condensation. Nat. Commun. 10, 2909.   DOI
27 Kageyama, T., Nakamura, M., Matsuo, A., Yamasaki, Y., Takakura, Y., Hashida, M., Kanai, Y., Naito, M., Tsuruo, T., Minato, N. and Shimohama, S. (2000) The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier. Brain Res. 879, 115-121.   DOI
28 Kang, Y. S., Lee, K., Lee, N. Y. and Terasaki, T. (2005) Donepezil, tacrine and α-phenyl-n-tert-butyl nitrone (PBN) inhibit choline transport by conditionally immortalized rat brain capillary endothelial cell lines (TR-BBB). Arch. Pharm. Res. 28, 443-450.   DOI
29 Jung, M. K., Kim, K. Y., Lee, N. Y., Kang, Y. S., Hwang, Y. J., Kim, Y., Sung, J. J., Mckee, A., Kowall, N., Lee, J. and Ryu, H. (2013) Expression of taurine transporter (TauT) is modulated by heat shock factor 1 (HSF1) in motor neurons of ALS. Mol. Neurobiol. 47, 699-710.   DOI
30 Adachi, Y., Ono, N., Imaizumi, A., Muramatsu, T., Andou, T., Shimodaira, Y., Nagao, K., Kageyama, Y., Mori, M., Noguchi, Y., Hashizume, N. and Nukada, H. (2018) Plasmaamino acid profile in severely frail elderly patients in Japan. Int. J. Gerontol. 12, 290-293.   DOI
31 Cashman, R. N., Durham, H. D., Blusztajn, K. J., Oda, K., Tabira, T., Shaw, T. I., Dahrouge, S. and Antel, P. J. (1992) Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 194, 209-221.   DOI
32 Brohawn, D. G., O'Brien, L. C. and Bennett, J. P., Jr. (2016) RNAseq analyses identify tumor necrosis factor-mediated inflammation as a major abnormality in ALS spinal cord. PLoS ONE 11, e0160520.   DOI
33 Gyawali, A. and Kang, Y. S. (2021b) Transport alteration of 4-phenyl butyric acid mediated by a sodium- and proton-coupled monocarboxylic acid transporter system in ALS model cell lines (NSC-34) under inflammatory states. J. Pharm. Sci. 110, 1374-1384.   DOI
34 Lee, K. E. and Kang, Y. S. (2018) L-Citrulline restores nitric oxide level and cellular uptake at the brain capillary endothelial cell line (TR-BBB cells) with glutamate cytotoxicity. Microvasc. Res. 120, 29-35.   DOI
35 Bahri, S., Curis, E., El Wafi, F. Z., Aussel, C., Chaumeil, J. C., Cynober, L. and Zerrouk, N. (2008) Mechanisms and kinetics of citrulline uptake in a model of human intestinal epithelial cells. Clin. Nutr. 27, 872-880.   DOI
36 Cheng, J., Tang, J. C., Pan, M. X., Chen, S. F., Zhao, D., Zhang, Y., Liao, H. B., Zhuang, Y., Lei, R. X., Wang, S., Liu, A. C., Chen, J., Zhang, Z. H., Li, H. T., Wan, Q. and Chen, Q. X. (2020) L-Lysine confers neuroprotection by suppressing inflammatory response via microRNA-575/PTEN signaling after mouse intracerebral hemorrhage injury. Exp. Neurol. 327, 113214.   DOI
37 Bae, S. Y., Xu Q., Hutchinson, D. and Colton, C. A. (2015) Y+ and y+ L arginine transporters in neuronal cells expressing tyrosine hydroxylase. Biochim. Biophys. Acta 1745, 65-73.
38 Petrov, D., Daura, X. and Zagrovic, B. (2016) Effect of oxidative damage on the stability and dimerization of superoxide dismutase 1. Biophys. J. 110, 1499-1509.   DOI